Select Publications

Journal articles

Thompson EW; Waltham M; Ramus SJ; Hutchins AM; Armes JE; Campbell IG; Williams ED; Thompson PR; Rae JM; Johnson MD; Clarke R, 2004, 'LCC15-MB cells are MDA-MB-435: A review of misidentified breast and prostate cell lines', Clinical and Experimental Metastasis, 21, pp. 535 - 541, http://dx.doi.org/10.1007/s10585-004-4117-z

Armes JE; Hammet F; De Silva M; Ciciulla J; Ramus SJ; Soo WK; Mahoney A; Yarovaya N; Henderson MA; Gish K; Hutchins AM; Price GR; Venter DJ, 2004, 'Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers', Oncogene, 23, pp. 5697 - 5702, http://dx.doi.org/10.1038/sj.onc.1207740

Werness BA; Ramus SJ; DiCioccio RA; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; Tsukada Y; Harrington P; Gayther SA; Ponder BAJ; Piver MS, 2004, 'Histopathology, FIGO Stage, and BRCA Mutation Status of Ovarian Cancers from the Gilda Radner Familial Ovarian Cancer Registry', International Journal of Gynecological Pathology, 23, pp. 29 - 34, http://dx.doi.org/10.1097/01.pgp.0000101083.35393.cd

Ramus SJ; Pharoah PDP; Harrington P; Pye C; Werness B; Bobrow L; Ayhan A; Wells D; Fishman A; Gore M; DiCioccio RA; Piver MS; Whittemore AS; Ponder BAJ; Gayther SA, 2003, 'BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases', Cancer Research, 63, pp. 417 - 423

Esteller M; Fraga MF; Guo M; Garcia-Foncillas J; Hedenfalk I; Godwin AK; Trojan J; Vaurs-Barrière C; Bignon YJ; Ramus S; Benitez J; Caldes T; Akiyama Y; Yuasa Y; Launonen V; Canal MJ; Rodriguez R; Capella G; Peinado MA; Borg A; Aaltonen LA; Ponder BA; Baylin SB; Herman JG, 2001, 'DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis', Human Molecular Genetics, 10, pp. 3001 - 3007, http://dx.doi.org/10.1093/hmg/10.26.3001

Ramus SJ; Fishman A; Pharoah PDP; Yarkoni S; Altaras M; Ponder BAJ, 2001, 'Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations', European Journal of Surgical Oncology, 27, pp. 278 - 281, http://dx.doi.org/10.1053/ejso.2000.1097

Russell PA; Pharoah PDP; De Foy K; Ramus SJ; Symmonds I; Wilson A; Scott I; Ponder BAJ; Gayther SA, 2000, 'Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers', International Journal of Cancer, 87, pp. 317 - 321, http://dx.doi.org/10.1002/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B

Werness BA; Parvatiyar P; Ramus SJ; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; DiCioccio RA; Wiest J; Tsukada Y; Ponder BAJ; Piver MS, 2000, 'Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53', Journal of the National Cancer Institute, 92, pp. 1088 - 1091, http://dx.doi.org/10.1093/jnci/92.13.1088

Werness BA; Ramus SJ; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; Dicioccio RA; Tsukada Y; Ponder A.J. B; Piver MS, 2000, 'Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations', Human Pathology, 31, pp. 1420 - 1424, http://dx.doi.org/10.1016/S0046-8177(00)80014-3

Knowles CH; Chir B; Gayther SA; Scott M; Ramus S; Anand P; Williams NS; Ponder BA, 2000, 'Idiopathic slow-transit constipation is not associated with mutations of the RET proto-oncogene or GDNF', Diseases of the Colon and Rectum, 43, pp. 851 - 857, http://dx.doi.org/10.1007/BF02238026

Werness BA; Ramus SJ; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; DiCioccio RA; Tsukada Y; Ponder BAJ; Piver MS, 2000, 'Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation', International Journal of Gynecological Pathology, 19, pp. 390 - 394, http://dx.doi.org/10.1097/00004347-200010000-00017

Ramus SJ; Bobrow LG; Pharoah PDP; Finnigan DS; Fishman A; Altaras M; Harrington PA; Gayther SA; Ponder BAJ; Friedman LS, 1999, 'Increased frequency of TP53 mutations in BRCAI and BRCA2 ovarian tumours', Genes Chromosomes and Cancer, 25, pp. 91 - 96, http://dx.doi.org/10.1002/(SICI)1098-2264(199906)25:2<91::AID-GCC3>3.0.CO;2-5

Csokay B; Udvarhelyi N; Sulyok Z; Besznyak I; Ramus S; Ponder B; Olah E, 1999, 'High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history', Cancer Research, 59, pp. 995 - 998

Ramus SJ; Forrest SM; Pitt DD; Cotton RGH, 1999, 'Genotype and intellectual phenotype in untreated phenylketonuria patients', Pediatric Research, 45, pp. 474 - 481, http://dx.doi.org/10.1203/00006450-199904010-00004

Gayther SA; Gorringe KL; Ramus SJ; Huntsman D; Roviello F; Grehan N; Machado JC; Pinto E; Seruca R; Halling K; MacLeod P; Powell SM; Jackson CE; Ponder BAJ; Caldas C, 1998, 'Identification of germ-line E-cadherin mutations in gastric cancer families of European origin', Cancer Research, 58, pp. 4086 - 4089

Ramus SJ; Kote-Jarai Z; Friedman LS; Van Der Looij M; Gayther SA; Csokay B; Ponder BAJ; Olah E, 1997, 'Analysis of BRCA1 and BRCA2 mutations in hungarian families with breast or breast-ovarian cancer [4]', American Journal of Human Genetics, 60, pp. 1242 - 1246

Ramus SJ; Friedman LS; Gayther SA; Ponder BAJ; Bobrow LG; Looji MVD; Papp J; Olah E, 1997, 'A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2', Nature Genetics, 15, pp. 14 - 15, http://dx.doi.org/10.1038/ng0197-14

Treacy E; Pitt JJ; Seller K; Thompson GN; Ramus S; Cotton RGH, 1996, 'In vivo disposal of phenylalanine in phenylketonuria: A study of two siblings', JOURNAL OF INHERITED METABOLIC DISEASE, 19, pp. 595 - 602, http://dx.doi.org/10.1007/BF01799832

Ramus SJ; Cotton RGH, 1996, 'Single-tube chemical cleavage of mismatch: Successive treatment with hydroxylamine and osmium tetroxide', BioTechniques, 21, pp. 216 - 220, http://dx.doi.org/10.2144/96212bm10

Ramus SJ; Cotton RGH, 1995, 'Polymorphism in the 3′ untranslated region of the phenylalanine hydroxylase gene detected by enzyme mismatch cleavage: evolution of haplotypes', Human Genetics, 96, pp. 741 - 743, http://dx.doi.org/10.1007/BF00210312

Ramus SJ; Treacy EP; Cotton RGH, 1995, 'Characterization of phenylalanine hydroxylase alleles in untreated phenylketonuria patients from Victoria, Australia: Origin of alleles and haplotypes', American Journal of Human Genetics, 56, pp. 1034 - 1041

Ramus SJ; Pitt DB; Cotton RGH, 1995, 'Genotype/phenotype correlations: Intellectual phenotypes in untreated PKU patients', International Pediatrics, 10, pp. 92 - 94

Ramus SJ; Cotton RGH, 1995, 'Mutations Ivs4nt1, 47delCT, and G148S identified in the phenylalanine hydroxylase gene by RT‐PCR of illegitimate transcripts and chemical cleavage of mismatch', Human Mutation, 6, pp. 250 - 251, http://dx.doi.org/10.1002/humu.1380060309

Cotton RGH; Dahl HHM; Forrest S; Howells DW; Ramus SJ; Bishop RE; Dianzani I; Saleeba JA; Palombo E; Anderson MJ; Milner CM; Campbell RD, 1993, 'Analysis of Sequence Contexts Flanking T·G Mismatches Leads to Predictions about Reactivity of the Mismatched T to Osmium Tetroxide', DNA and Cell Biology, 12, pp. 945 - 949, http://dx.doi.org/10.1089/dna.1993.12.945

Ramus SJ; Forrest SM; Pitt DB; Saleeba JA; Cotton RGH, 1993, 'Comparison of genotype and intellectual phenotype in untreated PKU patients', Journal of Medical Genetics, 30, pp. 401 - 405, http://dx.doi.org/10.1136/jmg.30.5.401

Dianzani I; Camaschella C; Saglio G; Ferrero GB; Ramus S; Ponzone A; Cotton RGH, 1993, 'Molecular analysis of contiguous exons of the phenylalanine hydroxylase gene: Identification of a new PKU mutation', Journal of Medical Genetics, 30, pp. 228 - 231, http://dx.doi.org/10.1136/jmg.30.3.228

Ramus SJ; Forrest SM; Saleeba JA; Cotton RGH, 1992, 'CpG hotspot causes second mutation in codon 408 of the phenylalanine hydroxylase gene', Human Genetics, 90, pp. 147 - 148, http://dx.doi.org/10.1007/BF00210760

Saleeba JA; Ramus SJ; Cotton RGH, 1992, 'Complete mutation detection using unlabeled chemical cleavage', Human Mutation, 1, pp. 63 - 69, http://dx.doi.org/10.1002/humu.1380010110

Ramus SJ; Forrest SM; Cotton RGH, 1992, 'Illegitimate transcription of phenylalanine hydroxylase for detection of mutations in patients with phenylketonuria', Human Mutation, 1, pp. 154 - 158, http://dx.doi.org/10.1002/humu.1380010211

Dianzani I; Ramus S; Cotton RGH; Camaschella C, 1991, 'A SPONTANEOUS MUTATION CAUSING UNSTABLE Hb HAMMERSMITH: DETECTION OF THE β42 TTT→TCT CHANGE BY CCM AND DIRECT SEQUENCING', British Journal of Haematology, 79, pp. 127 - 129, http://dx.doi.org/10.1111/j.1365-2141.1991.tb08026.x

Dianzani I; Camaschella C; Saglio G; Forrest SM; Ramus S; Cotton RGH, 1991, 'Simultaneous screening for β-thalassemia mutations by chemical cleavage of mismatch', Genomics, 11, pp. 48 - 53, http://dx.doi.org/10.1016/0888-7543(91)90100-S

Conference Papers

Minh TP; Berchuck A; Goode EL; Goodman MT; Hanley GE; Richardson J; Grout B; Chase A; Deurloo CM; Karlan BY; Van Gorp T; Matsuo K; McLean K; Pike MC; Schildkraut JM; Terry KL; DeFazio A; Webb PM; Pharoah PDP; Ramus SJ; Pearce CL, 2022, 'Environmental factors associated with residual disease after ovarian cancer primary cytoreduction surgery', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, LA, New Orleans, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), LA, New Orleans, 08 April 2022 - 13 April 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000892509508075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Xu X; Wang Y; Bryce N; Tang K; Meagher NS; Kang EY; Kelemen LE; Köbel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW, 2021, 'Abstract 1045: Combined targeting of actin/tropomyosin and microtubules underlies a potential treatment strategy of epithelial ovarian cancer with cell-cycle dependent synergy', in Cancer Research, American Association for Cancer Research (AACR), pp. 1045 - 1045, http://dx.doi.org/10.1158/1538-7445.am2021-1045

Xu X; Wang Y; Bryce N; Tang K; Meagher NS; Kang EY; Kelemen LE; Kobel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW, 2021, 'Combined targeting of actin/tropomyosin and microtubules underlies a potential treatment strategy of epithelial ovarian cancer with cell-cycle dependent synergy.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000680263503257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Talhouk A; George J; Wang C; Goode E; Ramus S; Doherty J; Bowtell D; Anglesio M, 2020, 'Abstract A03: PrOTYPE (Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE): The development and validation of a clinical-grade consensus classifier for the molecular subtypes of high-grade serous tubo-ovarian cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. A03 - A03, http://dx.doi.org/10.1158/1557-3265.ovca19-a03

Pavanello M; Dicks E; Song H; Ariff A; Bolithon A; Intermaggio MP; Pinese M; Moysich K; Odunsi KO; Goode E; Bowtell DD; Fasching P; Doherty JA; Modugno F; Kjær SK; Webb PM; Wu A; deFazio A; James P; Subramanian D; Campbell I; Gayther SA; Pharoah PDP; Ramus SJ, 2020, 'Abstract B37: Germline mutations in new susceptibility genes for non-high-grade serous ovarian cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. B37 - B37, http://dx.doi.org/10.1158/1557-3265.ovca19-b37

Garsed D; Pandey A; Fereday S; Alsop K; Wouters M; Saner F; Kennedy C; Pearce C; Pike M; Ramus S; Kobel M; deFazio A; Goode E; Nelson B; Bowtell D, 2020, 'Abstract IA05: Molecular analysis of exceptional response in high-grade serous ovarian cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. IA05 - IA05, http://dx.doi.org/10.1158/1557-3265.ovca19-ia05

Millstein J; Budden T; Goode EL; Anglesio MS; Talhouk A; Huntsman DG; Bowtell DD; Brenton JD; Doherty JA; Pharoah PPD; Ramus SJ, 2020, 'Abstract IA12: The Ovarian Tumour Tissue Analysis Consortium: Stratified Prognosis of Ovarian Tumors (OTTA-SPOT) signature for high-grade serous ovarian cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. IA12 - IA12, http://dx.doi.org/10.1158/1557-3265.ovca19-ia12

Garsed DW; Pandey A; Fereday S; Alsop K; Wouters MC; Saner F; Beach JA; Milne K; Kennedy CJ; Hendley J; Traficante N; Pearce CL; Pike MC; Ramus SJ; Köbel M; Nelson BH; Goode EL; deFazio A; Bowtell DD, 2019, 'Abstract 2722: The genomic landscape of high-grade serous ovarian cancer in long-term survivors', in Molecular and Cellular Biology / Genetics, American Association for Cancer Research, pp. 2722 - 2722, presented at Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA, http://dx.doi.org/10.1158/1538-7445.sabcs18-2722

Nazeran T; Mason M; Lee S; Gibson-Wright B; Milne K; Goode E; Ramus S; Huntsman D; Nelson B; Talhouk A; Kobel M; Anglesio M, 2019, 'Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Cancers', in LABORATORY INVESTIGATION, NATURE PUBLISHING GROUP, MD, National Harbor, presented at 108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - Unlocking Your Ingenuity, MD, National Harbor, 16 March 2019 - 21 March 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000478081102099&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nazeran T; Mason M; Lee S; Gibson-Wright B; Milne K; Goode E; Ramus S; Huntsman D; Nelson B; Talhouk A; Kobel M; Anglesio M, 2019, 'Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Cancers', in MODERN PATHOLOGY, NATURE PUBLISHING GROUP, MD, National Harbor, presented at 108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - Unlocking Your Ingenuity, MD, National Harbor, 16 March 2019 - 21 March 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000478915503099&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Manchanda R; Gaba F; Bottla K; Mousa K; Burnell M; Kalsi J; Gentry-Maharaj A; Antoniou A; Blyuss O; Zaikin A; Lee A; Lanceley A; Sanderson S; Waller J; Gayther S; Ramus S; Wallis Y; Skates S; Menon U; Jacobs I, 2017, 'PREDICTING RISK OF OVARIAN MALIGNANCY IMPROVED SCREENING AND EARLY DETECTION FEASIBILITY STUDY (PROMISE-FS)', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, pp. 1944 - 1944, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423235205227&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chornokur G; Lin H-Y; Monteiro A; Schildkraut J; Goode EL; Pharoah PDP; Gayther SA; Ramus S; Sellers TA; Phelan CM, 2016, 'Abstract A50: Mitochondrial metabolism gene variants are associated with risk and survival in epithelial ovarian cancer (EOC)', in Molecular Cancer Research, American Association for Cancer Research (AACR), pp. A50 - A50, http://dx.doi.org/10.1158/1557-3125.metca15-a50

Bolton KL; Tyrer J; Song H; Ramus S; Jones C; Notaridou M; Chanock SJ; Garcia-Closas M; Chenevix-Trench G; Gayther S; Pharoah PDP, 2010, 'Abstract 4729: A genome-wide association study of ovarian cancer prognosis identifies a novel locus for aggressive serous cancer on 19p13', in Cancer Research, American Association for Cancer Research (AACR), pp. 4729 - 4729, http://dx.doi.org/10.1158/1538-7445.am10-4729

Ramus S; Cotton RGH, 1995, 'CCM - Chemical cleavage of mismatch', in Landegren U (ed.), LABORATORY PROTOCOLS FOR MUTATION DETECTION, OXFORD UNIV PRESS, SWEDEN, VISBY, pp. 50 - 53, presented at 3rd International Workshop on Mutation Detection - Mutation Detection 1995, SWEDEN, VISBY, 18 May 1995 - 21 May 1995, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996BF52N00010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Pitiyarachchi O; Lee YC; Ramus SJ; defazio A; Friedlander M, 2022, 'Rates of somatic variants in homologous recombination DNA repair deficiency genes in older patients with high-grade serous ovarian carcinoma', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000879941200024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mahony DO; Ramus SJ; Southey MC; Hadjisavvas A; Antoniou AC; Goldgar DE; Spurdle AB; Michailidou K, 2022, 'Classification of Variants of Uncertain Significance (VUS) in the BRCA1 and BRCA2 Genes Based on Ovarian Tumor Pathology Characteristics', in GENETIC EPIDEMIOLOGY, WILEY, Vol. 46, pp. 520 - 521, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000850044000128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Phung MT; Berchuck A; Goode EL; Goodman MT; Hanley GE; Richardson J; Grout B; Chase A; Deurloo CM; Karlan BY; Van Gorp T; Matsuo K; McLean K; Pike MC; Schildkraut JM; Terry KL; DeFazio A; Webb PM; Pharoah PDP; Ramus SJ; Pearce CL, 2022, 'Abstract 2248: Environmental factors associated with residual disease after ovarian cancer primary cytoreduction surgery', in Cancer Research, American Association for Cancer Research (AACR), Vol. 82, pp. 2248 - 2248, http://dx.doi.org/10.1158/1538-7445.am2022-2248

Meagher NS; Hamilton PT; Anglesio MS; Harris HR; Konecny GE; Schildkraut JM; Talhouk A; Friedlander ML; Pearce CL; Pike MC; Kobel M; Doherty JA; Goode EL; Nelson BH; DeFazio A; Ramus SJ, 2022, 'Multi-modal immune profiling of mucinous ovarian carcinoma: analysis from the Ovarian Tumor Tissue Analysis/Multidisciplinary Ovarian Cancer Outcomes Group consortia', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, Vol. 208, http://dx.doi.org/10.4049/jimmunol.208.Supp.179.04

Mahony DO; Ramus SJ; Southey M; Hadjisavvas A; Meagher NS; Antoniou AC; Goldgar D; Spurdle A; Michailidou K, 2022, 'Use of ovarian cancer tumour pathology characteristics to aid classification of Variants of Uncertain Significance (VUS) in the BRCA1 and BRCA2 genes', in EUROPEAN JOURNAL OF HUMAN GENETICS, SPRINGERNATURE, Vol. 30, pp. 418 - 419, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000779367702077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1


Back to profile page